Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

JOSHUA Z PRESS

Allopathic & Osteopathic Physicians Obstetrics & Gynecology

NPI
1740475383
CMS profile
306575
Location
SEATTLE, WA

General Payments · PY2018–2024

$111,574.64

  • Reported across 151 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$19,525.81

29 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $18,802.99 21
ABBVIE INC. $203.36 2
GlaxoSmithKline, LLC. $199.12 2
Myriad Genetic Laboratories, Inc. $148.84 1
ImmunoGen, Inc. $118.65 1
Merck Sharp & Dohme Corporation $52.85 2

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $368.98 4
PY2019 $35,992.09 41
PY2020 $8,983.99 8
PY2021 $12,107.16 19
PY2022 $7,528.44 24
PY2023 $27,068.17 26
PY2024 $19,525.81 29

Payment records · PY2024 (29)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $131.34 04/04/2024 Food and Beverage Undisputed 01/23/2026 1105310762 CMS
ABBVIE INC. $72.02 04/11/2024 Food and Beverage Undisputed 01/23/2026 1105310766 CMS
AstraZeneca Pharmaceuticals LP $117.00 01/26/2024 Food and Beverage Undisputed 01/23/2026 1104375777 CMS
AstraZeneca Pharmaceuticals LP $82.86 04/17/2024 Food and Beverage Undisputed 01/23/2026 1105680689 CMS
AstraZeneca Pharmaceuticals LP $16.44 04/30/2024 Food and Beverage Undisputed 01/23/2026 1105644652 CMS
AstraZeneca Pharmaceuticals LP $136.00 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1104352084 CMS
AstraZeneca Pharmaceuticals LP $120.00 05/21/2024 Food and Beverage Undisputed 01/23/2026 1104563566 CMS
AstraZeneca Pharmaceuticals LP $256.68 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1104721503 CMS
AstraZeneca Pharmaceuticals LP $49.49 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1105582420 CMS
AstraZeneca Pharmaceuticals LP $297.00 05/21/2024 Travel and Lodging Undisputed 01/23/2026 1105654968 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 06/06/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105608899 CMS
AstraZeneca Pharmaceuticals LP $23.14 06/26/2024 Food and Beverage Undisputed 01/23/2026 1104698754 CMS
AstraZeneca Pharmaceuticals LP $100.00 07/11/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1105885921 CMS
AstraZeneca Pharmaceuticals LP $60.63 09/05/2024 Travel and Lodging Undisputed 01/23/2026 1104337126 CMS
AstraZeneca Pharmaceuticals LP $31.62 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104641131 CMS
AstraZeneca Pharmaceuticals LP $23.75 09/05/2024 Food and Beverage Undisputed 01/23/2026 1104689272 CMS
AstraZeneca Pharmaceuticals LP $624.38 09/05/2024 Travel and Lodging Undisputed 01/23/2026 1104740719 CMS
AstraZeneca Pharmaceuticals LP $670.88 09/05/2024 Travel and Lodging Undisputed 01/23/2026 1105337085 CMS
AstraZeneca Pharmaceuticals LP $117.93 09/05/2024 Food and Beverage Undisputed 01/23/2026 1105456002 CMS
AstraZeneca Pharmaceuticals LP $30.19 09/06/2024 Food and Beverage Undisputed 01/23/2026 1105472241 CMS
AstraZeneca Pharmaceuticals LP $5,500.00 09/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1104392513 CMS
AstraZeneca Pharmaceuticals LP $125.00 11/06/2024 Food and Beverage Undisputed 01/23/2026 1126677818 CMS
AstraZeneca Pharmaceuticals LP $4,920.00 11/14/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1126679250 CMS
GlaxoSmithKline, LLC. $95.15 01/25/2024 Food and Beverage Undisputed 01/23/2026 1116310643 CMS
GlaxoSmithKline, LLC. $103.97 03/06/2024 Food and Beverage Undisputed 01/23/2026 1115922818 CMS
ImmunoGen, Inc. $118.65 01/16/2024 Food and Beverage Undisputed 01/23/2026 1099941763 CMS
Merck Sharp & Dohme LLC $34.95 06/26/2024 Food and Beverage Undisputed 01/23/2026 1141752954 CMS
Merck Sharp & Dohme LLC $17.90 07/19/2024 Food and Beverage Undisputed 01/23/2026 1141752956 CMS
Myriad Genetic Laboratories, Inc. $148.84 03/27/2024 Food and Beverage Undisputed 01/23/2026 1152538299 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.